{{Rsnum
|rsid=6847149
|Gene=LRIT3
|Chromosome=4
|position=109878941
|Orientation=plus
|GMAF=0.1997
|Gene_s=GAR1,LRIT3,EGF
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 27.4 | 69.9
| HCB | 6.0 | 34.3 | 59.7
| JPT | 8.0 | 37.5 | 54.5
| YRI | 0.0 | 8.4 | 91.6
| ASW | 0.0 | 14.8 | 85.2
| CHB | 6.0 | 34.3 | 59.7
| CHD | 6.4 | 39.4 | 54.1
| GIH | 9.2 | 38.8 | 52.0
| LWK | 0.0 | 8.6 | 91.4
| MEX | 23.6 | 43.6 | 32.7
| MKK | 0.0 | 0.0 | 0.0
| TSI | 5.9 | 29.7 | 64.4
| HapMapRevision=28
}}{{PMID|17903301|OA=1
}} exercise heart rate, [[rs6847149]] ([[NOLA1]], p = 2.74*10(-6));

{{GWAS Summary
|SNP=rs6847149
|PubMedID=17903301
|Condition=Exercise treadmill test traits
|Gene=NOLA1
|Risk Allele=
|pValue=3.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs6847149
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903301; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study (Initial Sample Size: 1,238 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Exercise treadmill test traits.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356470
}}

{{PMID|17903299|OA=1
}} A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6847149
|overall_frequency_n=102
|overall_frequency_d=126
|overall_frequency=0.809524
|n_genomes=52
|n_genomes_annotated=0
|n_haplomes=89
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}